Image

Ranking: Top 15 CEE Pharma Manufacturers & Healthcare Companies


August 2026 | Based on revenue data | Powered by ISI EMIS


Top 15 companies by total revenue in Poland, Czechia, Hungary, Romania, Slovakia, Croatia & Bulgaria

Central and Eastern Europe (CEE) is home to a diverse pharmaceutical and healthcare sector, driven by established manufacturing capabilities, skilled workforces, expanding healthcare demand, and growing investment in modernisation and innovation. Despite an almost universal nominal growth in public healthcare spending, widespread industry problems include deteriorating financial sustainability, workforce and geographical imbalances and structural inefficiencies in healthcare service delivery.

In terms of market players, the CEE represents a fragmented scene of large international groups and strong domestic manufacturers, privately owned healthcare providers and locally strong state hospitals whose scale is difficult to assess through standard international data sources.

The ranking of the top 15 pharma and healthcare companies by total revenue in Poland, Czechia, Hungary, Romania, Slovakia, Croatia and Bulgaria, gives you a clearer view of the competitive landscape across this dynamically developing industry in the region. By identifying leading companies and comparing their most recent financial performance, you can make better-informed strategic decisions in a complex and evolving regional market.

It helps you uncover hidden opportunities, identify potential partners, and make better-informed strategic decisions in a complex but high-potential market.

Fill the below form in to download the list:

.










Gain access to data, news and insights on + 2.5 M CEE companies, all in one place!

𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼 𝗶𝗻𝘃𝗲𝘀𝘁 𝗼𝗿 𝗼𝗽𝗲𝗿𝗮𝘁𝗲 𝗶𝗻 𝗖𝗲𝗻𝘁𝗿𝗮𝗹 𝗮𝗻𝗱 𝗘𝗮𝘀𝘁𝗲𝗿𝗻 𝗘𝘂𝗿𝗼𝗽𝗲?
Access unique company and industry intelligence to act before others. Learn more about our expanded product solution providing the verified analysis and data you need to 𝗺𝗮𝗸𝗲 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰, 𝗿𝗶𝘀𝗸, 𝗮𝗻𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗖𝗘𝗘.